Catalyst Pharmaceuticals (CPRX) News Today $20.34 +0.66 (+3.35%) Closing price 08/12/2025 04:00 PM EasternExtended Trading$20.26 -0.08 (-0.37%) As of 08/12/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CPRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Catalyst Pharmaceuticals: A Developing Story That's Cheap Enough4 hours ago | seekingalpha.comXTX Topco Ltd Sells 15,179 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 12 at 3:35 AM | marketbeat.comCetera Investment Advisers Has $1.41 Million Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 12 at 3:18 AM | marketbeat.comCatalyst Pharma (CPRX) Receives a Buy from Bank of America SecuritiesAugust 11 at 6:24 AM | theglobeandmail.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Rating Lowered to "Hold" at Wall Street ZenAugust 11 at 4:44 AM | americanbankingnews.comSierra Summit Advisors LLC Acquires New Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 10 at 7:35 AM | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Cut to "Hold" at Wall Street ZenAugust 10 at 2:03 AM | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Trading Down 10.4% - Here's WhyAugust 8, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (CPRX) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comCatalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business UpdateAugust 6, 2025 | globenewswire.comLambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)August 6, 2025 | globenewswire.comThree Seasons Wealth LLC Buys Shares of 20,324 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 6, 2025 | marketbeat.comFederated Hermes Inc. Decreases Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 6, 2025 | marketbeat.comComposite Rating For Catalyst Pharmaceuticals Jumps To 96August 5, 2025 | msn.comCatalyst Pharmaceutics to Report Q2 Earnings: What's in the Cards?August 5, 2025 | finance.yahoo.comCatalyst Pharmaceuticals Inc (CPRX) Q2 2025 Earnings Report Preview: What to ExpectAugust 5, 2025 | finance.yahoo.comLSV Asset Management Lowers Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 5, 2025 | marketbeat.comGSA Capital Partners LLP Lowers Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 5, 2025 | marketbeat.comCatalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of DirectorsAugust 4, 2025 | globenewswire.comAssetmark Inc. Purchases 12,434 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 31, 2025 | marketbeat.comCatalyst Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gainsJuly 30, 2025 | marketwatch.comCatalyst Pharmaceuticals (CPRX) Expected to Announce Quarterly Earnings on WednesdayJuly 30, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Clark Estates Inc. NYJuly 30, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Position Lifted by Envestnet Asset Management Inc.July 30, 2025 | marketbeat.comInvestors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen enviable returns of 404% over the past five yearsJuly 29, 2025 | finance.yahoo.comSheaff Brock Investment Advisors LLC Takes Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 29, 2025 | marketbeat.comBryce Point Capital LLC Sells 33,750 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 28, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Purchases 55,000 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 27, 2025 | marketbeat.comPacer Advisors Inc. Has $20.72 Million Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 27, 2025 | marketbeat.comZacks Research Has Bullish Estimate for CPRX Q2 EarningsJuly 26, 2025 | marketbeat.comAllianz Asset Management GmbH Increases Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 26, 2025 | marketbeat.comRoyce & Associates LP Has $38.76 Million Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 25, 2025 | marketbeat.comLegato Capital Management LLC Takes $1.30 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 24, 2025 | marketbeat.comVictory Capital Management Inc. Purchases 243,702 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 24, 2025 | marketbeat.comNew York State Common Retirement Fund Raises Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 24, 2025 | marketbeat.comGallacher Capital Management LLC Purchases New Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 22, 2025 | marketbeat.comLos Angeles Capital Management LLC Has $4.57 Million Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 22, 2025 | marketbeat.comCatalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025July 22, 2025 | globenewswire.comJackson Creek Investment Advisors LLC Lowers Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 19, 2025 | marketbeat.com21,275 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Purchased by Sigma Planning CorpJuly 19, 2025 | marketbeat.comBank of New York Mellon Corp Lowers Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 19, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Hussman Strategic Advisors Inc.July 18, 2025 | marketbeat.comCatalyst Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors despite daily gainsJuly 16, 2025 | marketwatch.comLokken Investment Group LLC Purchases New Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 14, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stake Lessened by DekaBank Deutsche GirozentraleJuly 13, 2025 | marketbeat.comPrincipal Financial Group Inc. Purchases 17,018 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 12, 2025 | marketbeat.comBanque Pictet & Cie SA Invests $561,000 in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 11, 2025 | marketbeat.comCambridge Investment Research Advisors Inc. Takes Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 10, 2025 | marketbeat.comWhy Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term - NasdaqJuly 9, 2025 | nasdaq.comStratos Wealth Advisors LLC Makes New $2.02 Million Investment in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)July 9, 2025 | marketbeat.com Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CPRX Media Mentions By Week CPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPRX News Sentiment▼0.800.75▲Average Medical News Sentiment CPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPRX Articles This Week▼157▲CPRX Articles Average Week Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BBIO News VRNA News ELAN News BPMC News ROIV News GRFS News LEGN News RVMD News RYTM News RNA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CPRX) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access